ATE206755T1 - Verwendungen einer proteinkinase von ton und neurofilament pk40 - Google Patents

Verwendungen einer proteinkinase von ton und neurofilament pk40

Info

Publication number
ATE206755T1
ATE206755T1 AT92915162T AT92915162T ATE206755T1 AT E206755 T1 ATE206755 T1 AT E206755T1 AT 92915162 T AT92915162 T AT 92915162T AT 92915162 T AT92915162 T AT 92915162T AT E206755 T1 ATE206755 T1 AT E206755T1
Authority
AT
Austria
Prior art keywords
kinases
neurofilament
clay
protein kinase
relating
Prior art date
Application number
AT92915162T
Other languages
English (en)
Inventor
Vernon M Ingram
Hanno M Roder
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE206755T1 publication Critical patent/ATE206755T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345—Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
AT92915162T 1991-08-09 1992-07-10 Verwendungen einer proteinkinase von ton und neurofilament pk40 ATE206755T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74288091A 1991-08-09 1991-08-09
PCT/US1992/005825 WO1993003148A2 (en) 1991-08-09 1992-07-10 Tau/neurofilament protein kinases pk40 and pk36

Publications (1)

Publication Number Publication Date
ATE206755T1 true ATE206755T1 (de) 2001-10-15

Family

ID=24986618

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00104460T ATE262584T1 (de) 1991-08-09 1992-07-10 Verwendung eines inhibitors von tau/neurofilament-proteinkinase pk40
AT92915162T ATE206755T1 (de) 1991-08-09 1992-07-10 Verwendungen einer proteinkinase von ton und neurofilament pk40

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00104460T ATE262584T1 (de) 1991-08-09 1992-07-10 Verwendung eines inhibitors von tau/neurofilament-proteinkinase pk40

Country Status (9)

Country Link
EP (2) EP1026237B1 (de)
JP (1) JPH06510427A (de)
AT (2) ATE262584T1 (de)
AU (1) AU675410B2 (de)
CA (1) CA2115151C (de)
DE (2) DE69233330T2 (de)
DK (2) DK0667898T3 (de)
ES (2) ES2165358T3 (de)
WO (1) WO1993003148A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE438716T1 (de) * 1991-12-06 2009-08-15 Max Planck Gesellschaft Verwendung von protein-kinasen zur diagnose und behandlung der alzheimer-krankheit
US7408027B1 (en) 1991-12-06 2008-08-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften Tools for the diagnosis and treatment of Alzheimer's disease
EP0646129A4 (de) * 1992-05-11 1995-07-19 Ludwig Inst Cancer Res Moleküle, welche ähnlich zur tyrosin kinase des rezeptor typs sind(13.01.94).
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
JP2004502884A (ja) * 2000-07-07 2004-01-29 ミリケン・アンド・カンパニー 改良された持続性撥水性および汚れ放出性を有する織物基体およびその製造方法
CN101084204B (zh) 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
MX354662B (es) * 2011-10-07 2018-03-14 Ac Immune Sa Anticuerpos fosfoespecificos que reconocen la tau.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05506842A (ja) * 1989-09-15 1993-10-07 ジェンシア・ファーマシュウティカルズ・インコーポレイテッド 神経変性状態の処置方法
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
WO1993003177A1 (en) * 1991-08-09 1993-02-18 Massachusetts Institute Of Technology Novel tau/neurofilament protein kinases
EP0544942A1 (de) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Neue Werkzeuge für die Diagnose und die Behandlung der Alzheimer-Krankheit

Also Published As

Publication number Publication date
DK1026237T3 (da) 2004-07-19
EP1026237A2 (de) 2000-08-09
WO1993003148A3 (en) 1993-04-01
CA2115151C (en) 2005-05-17
ES2165358T3 (es) 2002-03-16
DE69232121D1 (de) 2001-11-15
JPH06510427A (ja) 1994-11-24
AU2324092A (en) 1993-03-02
ES2216745T3 (es) 2004-11-01
CA2115151A1 (en) 1993-02-18
WO1993003148A2 (en) 1993-02-18
ATE262584T1 (de) 2004-04-15
EP1026237B1 (de) 2004-03-24
DE69232121T2 (de) 2002-06-20
DE69233330D1 (de) 2004-04-29
DK0667898T3 (da) 2002-02-04
EP1026237A3 (de) 2001-03-28
EP0667898B1 (de) 2001-10-10
DE69233330T2 (de) 2005-03-10
AU675410B2 (en) 1997-02-06
EP0667898A1 (de) 1995-08-23

Similar Documents

Publication Publication Date Title
ATE299145T1 (de) Neues multimerisierendes reagenz
NO158499C (no) Hydraulisk sementoppslemming.
NO165673C (no) Hydraulisk sementoppslemming.
EP1903112A3 (de) Activin-Rezeptoren-ähnliche Kinase, die zur TGF-Rezeptor-Familie und/oder zur BMP-Rezeptor-Familie gehört
DE69007310D1 (de) Bohrkrone mit Kraftausgleich.
DE69111596D1 (de) Verwendung von zwitterionen zur mobilisierung isoelektrisch fokussierter ampholytzonen.
ATE231505T1 (de) Neue heterocyclische/cyclische amine
DE69014213D1 (de) Bit-Planmodifikation.
NO874653D0 (no) Hydraulisk sementoppslemming.
DE60142828D1 (de) Modifizierte oligonukleotide zur unterscheidung von fehlpaarungen
DE69214220D1 (de) Organophiler Ton
DE69204290D1 (de) Verwendung von 1,2,2,3,3-pentafluorpropan.
DE3872558D1 (de) Duennschichtreaktoren zur umsetzung von methan.
DE3761072D1 (de) Blendenanordnung zur optoelektronischen abtastung von vorlagen.
ATE206755T1 (de) Verwendungen einer proteinkinase von ton und neurofilament pk40
ATE110074T1 (de) Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.
FI905815A0 (fi) Kompositioner med kontrollerad frigoerning.
DE3768040D1 (de) Geraet zur reproduktion von dokumenten.
DE69031965D1 (de) System zum Durchgang von Hilfsmittelinformation
DE58909276D1 (de) Verfahren zur Übertragung von Farbstoffen.
DE68905075D1 (de) Herstellung von tris(2-zyanaethyl)amin.
DK51690D0 (da) Specifikke, molekylaere dna-prober for maskulint genom af bos-typen
DE59200805D1 (de) Werkstückträger mit Hilfsträger zur Fertigung von elektrischen Spulen.
ATE57704T1 (de) Heterocyclische pentalenderivate zur verwendung bei der bekaempfung von mikroorganismen.
FR2711999B1 (fr) Pont démontable pour des besoins civils ou militaires.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee